CAR-T Therapies are recently preferred more over surgeries, chemotherapy and radiation. This therapy targets the cancer cells and strengthens the patient’s immune system against tumor. This is a type of therapy where the T- Cells derived from the patient’s blood is modified in the laboratory by adding a special protein receptor on the T-Cells that attack cancer cells.
Get More Details with Sample PDF Copy @ https://www.theinsightpartners.com/sample/TIPRE00003731/
CAR-T Cell Therapy Market Competitive Landscape and Key Developments:
- Bristol Myers Squibb Company
- Novartis AG
- Gilead Sciences Inc
- Johnson Johnson Services Inc
- CARsgenTherapeutics Co Ltd
- Aurora Biopharma
- Legend Biotech
- Pfizer Inc
- bluebird bio Inc
About Us:
The Insight Partners is a one stop industry research provider of actionable intelligence. We help our clients in getting solutions to their research requirements through our syndicated and consulting research services. We specialize in industries such as Semiconductor and Electronics, Aerospace and Defense, Automotive and Transportation, Biotechnology, Healthcare IT, Manufacturing and Construction, Medical Device, Technology, Media and Telecommunications, Chemicals and Materials.
Contact Us:
If you have any queries about this report or if you would like further information, please contact us:
Contact Person: Ankit Mathur
E-mail: [email protected]
Phone: +1-646-491-9876